RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19
NCT05787327
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
96
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Chinese Herb
DIAGNOSTIC_TEST:
Placebo
Sponsor
Chinese University of Hong Kong